1,218
Views
0
CrossRef citations to date
0
Altmetric
Drug Profile

Viloxazine extended-release capsules as an emerging treatment for attention-deficit/hyperactivity disorder in children and adolescents

, &
Pages 443-455 | Received 20 Nov 2023, Accepted 04 Mar 2024, Published online: 19 Mar 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.